A kinetic study of interactions of (Rp)- and (Sp)-adenosine cyclic 3',5'-phosphorothioates with type II bovine cardiac muscle adenosine cyclic 3',5'-phosphate dependent protein kinase.
A kinetic study of interactions of (Rp)- and (Sp)-adenosine cyclic 3',5'-phosphorothioates with type II bovine cardiac muscle adenosine cyclic 3',5'-phosphate dependent protein kinase.
复制标题
(Rp)-和(Sp)-腺苷环3,5-硫代磷酸酯与II型牛心肌腺苷环3,5-磷酸依赖性蛋白激酶相互作用的动力学研究。
DOI:
10.1021/bi00261a028
复制
发表时间:
1982
期刊:
影响因子:
2.9
通讯作者:
Kaiser,ET
中科院分区:
文献类型:
--
作者:
O'Brian,CA;Roczniak,SO;Bramson,HN;Baraniak,J;Stec,WJ;Kaiser,ET
S'. S'-phosphate (cAMP) binding sites on the regulatory subunit of the type II bovine cardiac muscle cAMP-dependent protein kinase was investigated by examining the interactions of (RP)-and (Sp)-adenosine cyclic 3', 5'-phosphorothioates (cAMPS) with these sites. While activation of the holoenzyme and binding to the regulatory subunit of the type II kinase were observed for both of these diastereomers, there were significant differences between the interactions of the cAMPS isomers with the enzyme. In particular, the SP isomer is more potent than the RP species not only in the activation of reconstituted, as well as directly isolated, holoenzyme but also in the in-hibition of [3H] cAMP binding to the regulatory subunit. A marked preference for the binding of the SP isomer to site 2 in the regulatory subunit exists. Hydrogen bonding of a functional group on the regulatory subunitwith preferential orientation toward the exocyclic oxygen rather than the sulfur of the thiophosphoryl residue may be involved in the observed selectivity of cAMPS binding and activation. In addition to our findings on the stereoselectivity of the binding of cAMPS to cAMP-dependent protein kinase, we have established a method for the reconstitution of holoenzyme from the purified subunits without subjecting the regulatory protein to dena-turing conditions. e cAMP-dependent protein kinase of bovine cardiac muscle is thought to occur in two inactive, tetrameric forms, each containing two identical catalytic subunits and two type I or two type II regulatorysubunits (Corbin et al., 1978; Erlichmann et al., 1973; Bechtel & Beavo, 1974; Beavo et al., 1974). Autophosphorylation sites existin the type II but not in the type I regulatory dimer (Corbin et al., 1974, 1975). The binding of cAMP1 to the regulatory subunits is believed to cause the holoenzyme to dissociate into two active catalytic subunits and a dimer of regulatory subunits (Corbin et al., 1978). It has been determined that each type II regulatory monomer has two nonidentical cAMP binding sites (Rannels & Corbin, 1980), and the stoichiometry of binding sufficient for activation appears to be two cAMP molecules per holoenzyme (Kerlavage & Taylor, 1982).